Pain

Data show 82% of studies reported significant abstinence from psychomotor stimulant use at the end-of-treatment assessment.

Data show prevalence of pain increased with age in all age groups, while it was lower among men and non-Hispanic Asian adults.

Data show skeletal muscle relaxant associated with increased risk of fall-related injury (OR 1.28) and all-cause hospitalization (OR 1.11).

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

A new study finds a 2-step chronic pain screening process helped identify patients in primary care with previously undocumented chronic pain.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Data show 3 life-threatening adverse events required intervention, but were unrelated to buprenorphine induction.

Enrollees with OUD receiving medication treatment increased from 47.8% in 2014 to 57.1% in 2018

Physicians who performed well on ABIM examination less likely to prescribe opioids for back pain compared to physicians who did not perform well.

Data show pain scores were significantly lower in ibuprofen treatment group compared to acetaminophen.

Patient-reported scores showed no overall differences across 3- and 12- month follow-up.

Opioid prescription decreased substantially in 2 years following 2016 CDC guideline for prescribing opioids for chronic pain.

Data show 1 in 5 surgical patients who receive prescriptions for benzodiazepine go on to use them persistently.

Stress induced by COVID-19 is driving opioid addiction risks. An expert weighs in on addressing one matter to resolve another.

Weekly number of opioid-related deaths increased 135% over study period.

A longer duration of medication use during pregnancy was linked to decreases in odds of overdose and preterm birth.

Patients with opioid-induced constipation had more frequent, painful constipation symptoms, compared to those with chronic idiopathic constipation.

Veterans are particularly susceptible to opioid dependence and abuse.

A daily opioid dose higher than 90 MME is associated with 3-fold risk increase, compared to 90 MME or lower.

Data show sublingual sufentanil tablets did not affect pain scores, but did benefit patient satisfaction outcomes.

Data show a nearly 30% reduction in individuals filling naloxone prescriptions at the start of COVID-19 pandemic, with no significant recovery observed.

The treatment shows superior results over bupivacine solution, with a significant number of patients becoming opioid-free.

Prescription rates of buprenorphine and opioid analgesics for OUD fell during the COVID-19 pandemic for new patients, but existing treatment was not affected.

A new study compares patients self-reported outcomes after depot or daily sublingual buprenorphine treatment, including satisfaction and burden rates.

Despite higher risk of adverse effects in patients with opioid use disorder, benzodiazepine does not undo protection benefits of buprenorphine.